Brazil Voids Merck Patent On AIDS Drug
JoeBackward writes "Merck has this useful anti-AIDS drug Elfavirenz, and Brazil has lots of poor people with AIDS. So, after trying really hard to get Merck to cooperate on pricing, the Brazilian government has decided to take a 'compulsory license' to the patent, and get the drug from a factory in India. This compulsory license is basically a way to take the patent by eminent domain." This move gives Brazil one more thing in common with Thailand, both of which have blocked YouTube. Thailand's compulsory licensing of Elfavirenz and Plavix has landed the country on the US's watch list for piracy.
it s nice to see humanity win one for a change
who can really put a price on that?
back in the day we didnt have no old school
you know what else Brazil and Thailand have in common? A boisterous tourism industry and hot girls. Seriously, what does youtube have to do with this story?
> Rather than making the composition of the drug open, don't release what's actually in it,
:)
> and just test it as a 'black box,' show empirically through tests that it's effective and
> reasonably safe, but dope the actual pills with a lot of random substances that make it
> difficult to reverse-engineer
I really can't forsee any form of DRM for chemical compounds. It's quite like DRM for music - at one point the music has to be played on a speaker. Similarly, if you're going to make a drug, you're going to have to give the pill out at which point you have the whole field of analytical chemistry (mass spec, HPLC etc) at your disposal!
Furthermore, adding random substances to it, doesn't really hinder the identification process - they'd just show up as separate peaks on the spectrum. In addition randomly adding substances to a drug mixture would probably mess up pharmacokinetics which would have to be restudied all over again.
Unfortunately the chemical world is a little bit messier than the digital world
Year 2001: 5 (five) US citizens die in Anthrax scare. US government immediately starts proceedings for compulsory license for Cipro, wrestling the patent rights away from foreign company and competitor Bayer. This stance is widely praised as proactive and protecting the precious lives of US citizens.
Year 2007: Tens of thousand of people die in Brazil each year from AIDS because they cannot afford patented medication. Action from Brazil to force compulsory licensing is widely denounced as destroying the worldwide pharma industry, especially by US commentators.
Well...
Stop believing big pharma's FUD.
There are several significant factors undercutting this supposed billion dollar price tag. The first is that AIDS research has received significant public funding, and second is that antiretroviral drugs have the shortest time to approval of any class of drugs, approximately half the time of normal clinical trials (the mean time for antiretrovirals is 44.6 months, compared to an industry average of 87.4 months).
See this report from Doctors Without Boarders for more information.
- Sales revenue: 22,636.0
So where does the money go?- Manufacturing costs: 6,001.1
- Marketing & adminstrative costs: 8,165.4
- R&D: 4,782.9
Only 20% of the price of each pill goes toward future research and development... Marketing & administrative costs are double that. Ouch.